Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0224
-0.0016 (-6.67%)
Sep 15, 2026, 3:51 PM EST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $6.63 million as of September 16, 2026. Its market cap has decreased by -55.36% in one year.
Market Cap
6.63M
Enterprise Value
-5.24M
Revenue
5.92M
Ranking
n/a
PE Ratio
0.26
Stock Price
$0.02
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 6.63M, a decrease of -99.46%. That is a compound annual growth rate of -36.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 6.63M | -3.85% |
| Dec 31, 2025 | 6.89M | -95.00% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 9.01M |
| Institute of Biomedical Research | 7.97M |
| Curative Biotechnology | 7.15M |
| OSR Health | 7.06M |
| Reviva Pharmaceuticals Holdings | 7.01M |
| Hepion Pharmaceuticals | 6.93M |
| TRON Group | 5.52M |
| LianMedical | 5.30M |